An Investigation of Psilocybin on Behavioural and Cognitive Symptoms of Adults With Fragile X Syndrome
Clinical trial NCT05832255 · SUSPENDED
Trial details
- NCT number
- NCT05832255
- Sponsor
- Nova Mentis Life Science Corp
- Status
- SUSPENDED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-28
- Primary completion
- 2024-05-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.